Ghost Tree Capital »

Annexon shares owned by Ghost Tree Capital

Quarter-by-quarter ownership of Annexon (ANNX) shares owned by Ghost Tree Capital from 13F filings

Historical chart of Ghost Tree Capital investment in Annexon

Tip: Access up to 7 years of quarterly data

All positions including Annexon held by Ghost Tree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Annexon by Ghost Tree Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.8M 650k 5.92
2024-06-30 $2.6M 525k 4.90

More positions owned by Ghost Tree Capital

Spdr Ser Tr S&p Biotech Put Option (XBI)
Biohaven Call
Sarepta Therapeutics (SRPT)
Novo-nordisk A S Adr (NVO)
Blueprint Medicines (BPMC)
Axsome Therapeutics (AXSM)
Tarsus Pharmaceuticals (TARS)
Perspective Therapeutics Com New (CATX)
Cg Oncology (CGON)
Roivant Sciences SHS (ROIV)
Vaxcyte (PCVX)
Insmed Com Par $.01 (INSM)
Viking Therapeutics (VKTX)
Syndax Pharmaceuticals (SNDX)
Janux Therapeutics (JANX)

View all positions for Ghost Tree Capital

Top funds holding Annexon

FMR
BlackRock
BVF
Redmile Group
Vanguard Group
Bain Capital Life Sciences Investors
Bellevue Group
Millennium Management
Woodline Partners
Opaleye Management
Candriam Luxembourg S.C.A.
Geode Capital Management
Goldman Sachs Group
Ameriprise Financial
Polygon Management

View all funds holding Annexon